Chiu et al12 | NCITS | Two tertiary NICUs; 50 and 18 beds | Boston, USA; 2005 to 2008 | To evaluate effectiveness and safety of a guideline restricting vancomycin use | | Change of vancomycin use from 6.9/1000 PD to 4.5/PD in hospital 1 (p=0.01), and from 17/1000 PD to 6.4/1000 PD in Hospital 2 (p<0.0001) Change of infants exposed to vancomycin from 5.2/1000 PD to 3.1/1000 PD (p=0.008) in hospital 1, and from 10.8/1000 PD to 5.5/1000 PD in hospital 2 (p=0.009)
|
Ting et al16 | NCBA | Single NICU | Vancouver, Canada; 2010 to 2015 | To evaluate the effectiveness of ASP on antibiotic prescription practices | Audit and feedback Revision of antibiotic guideline Education on judicious antimicrobial use New technology to reduce time of microbiological diagnosis
| Change of inappropriate meropenem antibiotic—days from 1.89 to 1.96 (RR (95% CI): 1.04 (0.70–1.52)) per 1000 DOT Change of inappropriate cefotaxime antibiotic—days from 3.56 to 1.73 (RR (95% CI): 0.49 (0.33–0.71)) per 1000 DOT Change of inappropriate vancomycin antibiotic—days from 2.70 to 1.01 (RR (95% CI): 0.37 (0.22–0.60)) per 1000 DOT No improvement of inappropriate antibiotic prescriptions in very low birthweight infants No changes in inappropriate courses of linezolid
|
Nzegwu et al13 | NCITS | Single level IV NICU; 54 beds | Boston, USA; 2011–2016 | To evaluate an ASP on prescription practices | Development of clinical guidelines on the treatment of common neonatal infections Audit and feedback by a multidisciplinary ASP team Education on judicious antibiotic use
| Change of monthly antibiotic use from 270.4 to 258.8 DOT/1000 PD (p=0.669) Change of monthly ampicillin use from 118.6 to 103.4 DOT/1000 PD (p=0.037) No significant changes of vancomycin, cefotaxime and gentamicin/tobramycin Decrease of late-onset sepsis evaluation and prescription events per 100 NICU days (p<0.0001), with an average reduction of 2.65 evaluations per year per provider Clinical guidelines adherence of 98.75%
|
Lee et al14 | NCITS | Single paediatric centre, NICU; 60 beds | Memphis, USA; 2010 to 2013 | To evaluate the effectiveness of a new guideline about antimicrobial use for common infections and early-onset sepsis on antimicrobial use | Development of a guideline taking into account local antibiograms Education on judicious antimicrobial use Regular audits and feedback
| |
Mc Carthy et al17 | NCBA | Single NICU; 50 beds | Cork, Ireland; September 2016 to March 2017 | To evaluate the effectiveness of a local guideline in combination with audits and electronic prescribing on antimicrobial use | | Change of antibiotic use from 572 to 417 DOT/1000 PD (p<0.0001) Change of prolonged antibiotic use (>36 hours) from 82 to 7.5 DOT/1000 PD (p=0.0004) Change of prolonged antibiotic use (>5 days) from 46.5 to 7 DOT/1000 PD (p=0.0009)
|
Cantey et al15 | NCITS | Single level 3C NICU; 90 beds | Texas, USA; March 2012 to June 2014 | To inform ASP strategies in a NICU, determining areas where antibiotic use could be reduced safety | Extension of ruled-out sepsis courses beyond 48 hours Treatment duration for culture-negative pneumonia Treatment duration for culture-negative sepsis
| Change of antibiotic use from 343.2 to 252.2 DOT/1000 PD (p<0.0001) Change of 48 hours rule-out courses (percentage discontinued <48 hours) from 32% to 95% (p<0.0001) Change of infants with culture-negative sepsis treated <5 days from 31% to 62% (p=0.04) Change of pneumonia treatments<5 days from 36% to 72% (p<0.0001)
|